Physician profile
Rick A Carpenter
NPI 1487877403
$1,153.71
in general payments reported to CMS, 2019-2025
17 companies · $453 in 2025
The $453 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $118 · 2020: $67.43 · 2021: $61.91 · 2022: $57.99 · 2023: $136 · 2024: $259 · 2025: $453.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $848.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $848.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $289.64 | 2021-2025 | Tryptyr, Rocklatan, Rhopressa |
| Amgen INC. | $148.28 | 2024-2025 | Tepezza |
| Tarsus Pharmaceuticals, INC. | $146.29 | 2024-2025 | Xdemvy |
| Horizon Therapeutics Plc | $114.78 | 2023 | Tepezza |
| Sun Pharmaceutical Industries INC. | $100.07 | 2019-2024 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $87.15 | 2019-2021 | |
| Astellas Pharma US INC | $43.27 | 2024 | Izervay |
| Boston Scientific Corporation | $37.84 | 2025 | Accolade Sr |
| Allergan, INC. | $26.74 | 2019-2020 | |
| Oyster Point Pharma, INC. | $22.16 | 2022 | |
| Alexion Pharmaceuticals, INC. | $21.52 | 2023 | Soliris |
| Viiv Healthcare Company | $21.00 | 2024 | Cabenuva |
| Shire North American Group INC | $20.88 | 2019 | |
| Bausch & Lomb Americas INC. | $20.87 | 2022 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $17.97 | 2019 | |
| Sight Sciences, INC. | $15.85 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rick Carpenter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.